Abera Bioscience AB
Maria Alriksson is an experienced executive in the biotech and e-commerce sectors, currently serving as the Chief Executive Officer at Abera Bioscience AB, where the focus is on developing innovative vaccines and immunotherapies. Previously, Maria worked as a Senior Consultant at Omniarch and held an interim leadership role in e-commerce strategy at Aller Media. Maria's background includes significant roles at apotea.se as Head of Business Development and Site Manager, Chief Marketing Officer at OP5, and Head of Global Marketing at Aritco Lift AB. Earlier career experiences include CEO at Xbrane Bioscience AB, Brand Manager at GlaxoSmithKline, and various positions during academic training. Maria holds a Master of Science in Industrial Engineering and Management from Linköping University, along with additional degrees in Entrepreneurship and Business Administration.
This person is not in any teams
Abera Bioscience AB
Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide. Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.